Microbiotix, Inc. is a biopharmaceutical company focused on the discovery and development of proprietary small molecule drugs that target serious infectious diseases. Microbiotix has active projects in the antibacterial, antiviral, and antiparasitic areas, including many diseases that are underserved by the pharmaceutical industry, and we collaborate extensively with academic investigators to solve complex problems in these areas.
The Company's lead therapeutic compound, MBX-400, a novel agent for the treatment of human cytomegalovirus, is currently in Phase IB clinical testing. MBX-400 is a non-natural nucleoside analog that has shown improved activity against resistant strains and less toxicity than existing HCMV therapies.
Click on the link below to view the posting in PDF format:
Pease e-mail resumes to our employment inbox (email@example.com). We thank all applicants for their interest, however due to the volume of applicants, we will only contact those applicants with whom we are scheduling an interview. All attachments must be sent in either .pdf (preferred) or .doc format.